Brief: VBI Vaccines Reports First Quarter 2023 Financial Results
15/05/2023 13:16
May 15 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* VBI VACCINES INC - PREVIOUSLY ANNOUNCED COST-REDUCTION
MEASURES
IN PLACE WITH EXPECTED REDUCTION IN OPERATING EXPENSES OF 30-35%
IN H2 2023
* VBI VACCINES INC - ENDED Q1 OF 2023 WITH $40.4 MILLION IN
CASH
Source text for Eikon: ID:nBwblpKrMa
Further company coverage: VBIV.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55